Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care.
about
The Art of Managing Conversions between Antiepileptic Drugs: Maximizing Patient Tolerability and Quality of Life.Independent predictors of delay in emergence from general anesthesia.Purines and the Anti-Epileptic Actions of Ketogenic Diets.Seizure treatment in transplant patients.Pattern of adverse events of antiepileptic drugs: results of the aESCAPE study in Poland.Patient considerations in the management of focal seizures in children and adolescents.Perampanel, a novel, non-competitive, selective AMPA receptor antagonist as adjunctive therapy for treatment-resistant partial-onset seizures.Adenosine receptors and epilepsy: current evidence and future potential.Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.Seizures in Pediatric Patients With Liver Transplant and Efficacy of Levetiracetam.Stopping antiepileptic drugs: when and why?Association of UGT2B7 and UGT1A4 Polymorphisms with Serum Concentration of Antiepileptic Drugs in Children.Preliminary Screening of a Classical Ayurvedic Formulation for Anticonvulsant ActivityPerampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307.The effect of uridine diphosphate glucuronosyltransferase (UGT)1A6 genetic polymorphism on valproic acid pharmacokinetics in Indian patients with epilepsy: a pharmacogenetic approach.Safety and tolerability of adjunctive brivaracetam as intravenous infusion or bolus in patients with epilepsy.Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
P2860
Q34158012-084FF92B-DE45-4D39-BE54-16E6C8D6CD6EQ35315690-30D1B668-4790-419B-A6BF-E08700B248E9Q35513799-FDEC5493-5978-46F7-9BC0-AD7215ACBA0DQ36851252-7A7AD740-AF8E-4FEE-A3CC-7D1E6CF56C1AQ37321910-AE04D19C-4DF5-4625-A50D-986FC7CA7FD3Q37702192-0DEDC362-6FDA-450E-AC75-8000728B0B42Q38069246-A79BADFD-3EAC-4A72-80F6-4C5CE353ED39Q38245140-7CF06180-090E-43D3-91F2-27176DDEDBE0Q38800995-9023DDB0-0E7A-4E69-A2B8-8E90CA60DE6EQ38831715-E7CCC2F1-7326-4C09-B53B-4225532BB0A2Q41818942-A87C8B1C-935D-45A2-BB84-FA5812FA13B3Q42213046-71FDC1EC-8DEE-499A-A8B3-6B1649D37987Q42328640-726D38FE-F175-4943-8C91-C5EF49BFF51EQ42664102-BB2D1B23-4FD4-4AAD-8F2B-4809AB1869D9Q44882854-6E95EF0C-24B4-4630-81FA-238143C5C9CFQ47853821-D3910495-05B2-4615-8E76-C2231B94AA5CQ54276194-AC45C6A9-DAE8-4531-8368-A740EB4C31CD
P2860
Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@en
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@nl
type
label
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@en
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@nl
prefLabel
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@en
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@nl
P2860
P1476
Minimizing AED adverse effects ...... rictal state in epilepsy care.
@en
P2093
Erik K St Louis
P2860
P304
P356
10.2174/157015909788848857
P577
2009-06-01T00:00:00Z